Table 4 |
||
|
Outcome of the 31 patients in the two groups |
||
|
DS (n = 15) |
CR (n = 16) |
|
|
|
||
|
Duration of therapy |
||
|
12 weeks |
8 |
12 |
|
14 weeks |
3 |
1 |
|
16 weeks |
3 |
2 |
|
20 weeks |
0 |
1 |
|
24 weeks |
1 |
0 |
|
Therapeutic failure |
0 |
0 |
|
Operation after therapy (n) |
2 |
1 |
|
Relapse |
0 |
0 |
|
Clinical sequelae n (%) |
9 (60) |
11 (69) |
|
Mild sequelae |
8 |
9 |
|
Moderate sequelae |
1 |
2 |
|
Severe sequelae |
0 |
0 |
|
|
||
|
Alp et al. BMC Infectious Diseases 2006 6:72 doi:10.1186/1471-2334-6-72 |
||
